We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
(+20%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$613M |
| 2 |
Match Group
MTCH
|
+$518M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
RTX Corp
RTX
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$828M |
| 2 |
Microsoft
MSFT
|
+$510M |
| 3 |
Gilead Sciences
GILD
|
+$465M |
| 4 |
Merck
MRK
|
+$376M |
| 5 |
Walmart Inc
WMT
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Primis Financial Corp
FRST
$404M
| $1.06M | ﹤0.01% |
109,617
-41,533
| -27% | -$400K |
|
|
STSA
2602
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $1.06M | ﹤0.01% |
36,894
+26,031
| +240% | +$603K |
|
2603
First Bancorp
FNLC
$399M
| $1.06M | ﹤0.01% |
48,786
+9,333
| +24% | +$192K |
|
|
AGS
2604
DELISTED
PlayAGS
AGS
| $1.06M | ﹤0.01% |
312,727
-39,287
| -11% | -$150K |
|
|
PARAA
2605
DELISTED
Paramount Global Class A
PARAA
| $1.05M | ﹤0.01% |
40,950
+6,609
| +19% | +$147K |
|
2606
Energy Fuels
UUUU
$3.53B
| $1.05M | ﹤0.01% |
692,718
+343,360
| +98% | +$546K |
|
|
AT
2607
DELISTED
Atlantic Power Corporation
AT
| $1.05M | ﹤0.01% |
522,817
-219,055
| -30% | -$436K |
|
2608
W&T Offshore
WTI
$518M
| $1.04M | ﹤0.01% |
456,477
+82,700
| +22% | +$210K |
|
|
CAMP
2609
DELISTED
CalAmp Corp.
CAMP
| $1.04M | ﹤0.01% |
5,643
-3,747
| -40% | -$579K |
|
2610
Genco Shipping & Trading
GNK
$1.1B
| $1.04M | ﹤0.01% |
165,445
-20,003
| -11% | -$116K |
|
2611
NN Inc
NNBR
$311M
| $1.04M | ﹤0.01% |
218,807
+42,856
| +24% | +$150K |
|
|
DMF
2612
DELISTED
BNY Mellon Municipal Income
DMF
| $1.03M | ﹤0.01% |
124,171
| – | – |
|
2613
Mastech Digital
MHH
$93.2M
| $1.03M | ﹤0.01% |
+39,838
| New | +$706K |
|
|
ROCC
2614
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $1.03M | ﹤0.01% |
108,377
+8,036
| +8% | +$62.1K |
|
|
AMAG
2615
DELISTED
AMAG Pharmaceuticals
AMAG
| $1.02M | ﹤0.01% |
133,382
-194,986
| -59% | -$1.49M |
|
|
DSSI
2616
DELISTED
Diamond S Shipping Inc. Common Shares
DSSI
| $1.02M | ﹤0.01% |
+127,261
| New | +$1.34M |
|
|
GTT
2617
DELISTED
GTT Communications, Inc.
GTT
| $1.02M | ﹤0.01% |
124,520
+11,725
| +10% | +$106K |
|
2618
Keros Therapeutics
KROS
$221M
| $1.01M | ﹤0.01% |
+26,970
| New | +$831K |
|
2619
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.7B
| $1.01M | ﹤0.01% |
18,800
| – | – |
|
2620
Clarus
CLAR
$143M
| $1.01M | ﹤0.01% |
87,160
-1,943
| -2% | -$19.7K |
|
2621
MeiraGTx Holdings
MGTX
$1.21B
| $1.01M | ﹤0.01% |
80,429
-7,299
| -8% | -$102K |
|
|
AKCA
2622
DELISTED
Akcea Therapeutics Inc
AKCA
| $1M | ﹤0.01% |
73,087
-4,431
| -6% | -$68.4K |
|
2623
MediciNova
MNOV
$66M
| $998K | ﹤0.01% |
184,027
+43,002
| +30% | +$228K |
|
2624
Cadiz
CDZI
$291M
| $995K | ﹤0.01% |
97,915
-30,681
| -24% | -$343K |
|
2625
Applied Optoelectronics
AAOI
$11.5B
| $993K | ﹤0.01% |
91,371
| – | – |
|
Similar funds
VFT
Nuveen's Q2 2020 Portfolio in Review
As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
- Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
- Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
- Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
- Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
- Nuveen opened 266 new positions and closed 200 in Q2 2020.
- Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.
Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.